Real-time monitoring and effector screening of APE1 based on rGO assisted DNA nanoprobe
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 633, 114394
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2019JJ50859, 2020JJ4005)
This publication has 29 references indexed in Scilit:
- Correction: Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-Α-Induced Activation of Il-8 Production in Liver Cancer Cell LinesPLOS ONE, 2013
- Base Excision RepairCold Spring Harbor Perspectives in Biology, 2013
- Scaling Up Digital Circuit Computation with DNA Strand Displacement CascadesScience, 2011
- A proximity-based programmable DNA nanoscale assembly lineNature, 2010
- Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancersBritish Journal of Cancer, 2010
- APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cellsLung Cancer, 2009
- Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNANucleic Acids Research, 2009
- Transcriptional Regulatory Functions of Mammalian AP-Endonuclease (APE1/Ref-1), an Essential Multifunctional ProteinAntioxidants & Redox Signaling, 2009
- The Exonuclease Activity of Human Apurinic/Apyrimidinic Endonuclease (APE1)Journal of Biological Chemistry, 2003
- Two distinct human DNA diesterases that hydrolyze 3′-blocking deoxyribose fragments from oxidized DNANucleic Acids Research, 1991